Living Cell Technologies

Make payments with PayPal - it's fast, free and secure! Learn about supporting IT History Society
  • 1987

Company Description

Living Cell Technologies develops insulin producing porcine pancreatic islets for the treatment of type 1 diabetes.

LCT is a cell-based biotechnology developing insulin producing porcine pancreatic islets for the treatment of type 1 diabetes . LCT's lead product, DIABECELL is in Phase II clinical trial. LCT's encapsulation technology immunoisolates cells and allows cell implants without the use of immunosuppressive drugs.

CrunchBase
Edit this page
Add a company to our database